The U.S. is a global leader in the health sector, driven heavily by its pioneering advancements in pharmaceuticals, biotech, and medical technology. This high-demand sector continues to experience massive expansion heading into 2026, fueled by breakthrough developments in genomic medicines, metabolic therapies, and AI-accelerated drug discovery.

The Northeast Corridor—stretching from Washington, D.C. to Boston, MA—acts as the nation's premier biopharma engine, anchoring major hubs in Boston, Philadelphia, New York City, and the greater Washington metro area. Bolstered by unprecedented public and private investment, these four interconnected Northeast markets have grown to support over 360,000 industry jobs, commanding more than $24 billion in combined annual NIH grants and venture capital funding, while pushing cumulative patent filings well past 26,000.

Mirroring this east coast success, the West Coast has rapidly solidified its status as an equally dominant powerhouse for life sciences and specialized medical engineering. Centered around major innovation hubs in San Francisco, San Diego, Seattle, and Los Angeles, the West Coast tech-bio ecosystem has scaled dramatically to meet rising global healthcare demands. Together, these four coastal cities now account for approximately 340,000 high-paying sector jobs.

Driven by a highly aggressive venture capital climate and elite research institutions, the West Coast commands over $18 billion in annual venture funding and NIH allocations, with its tech-forward workforce propelling total regional patent filings past the 28,000 threshold.